(19)
(11) EP 4 097 120 A1

(12)

(43) Date of publication:
07.12.2022 Bulletin 2022/49

(21) Application number: 20915510.0

(22) Date of filing: 27.03.2020
(51) International Patent Classification (IPC): 
C07K 7/06(2006.01)
C07K 7/50(2006.01)
 C07K 5/12(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 7/06; A61P 35/00; A61K 47/64; A61K 51/08; C07B 59/008
(86) International application number:
PCT/US2020/025522
(87) International publication number:
WO 2021/150258 (29.07.2021 Gazette 2021/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.01.2020 US 202016752690

(71) Applicant: Mainline Biosciences LLC
Malvern, PA 19355 (US)

(72) Inventors:
  • ZHANG, Junge
    Westfield, IN 46074 (US)
  • YAN, Liang, Zeng
    Carmel, IN 46033 (US)

(74) Representative: Herrero & Asociados, S.L. 
Cedaceros, 1
28014 Madrid
28014 Madrid (ES)

   


(54) ISOTOPICALLY LABELLED SELECTIVE CXCR4 BINDING PEPTIDE CONJUGATE AND METHODS FOR MAKING AND USING THE SAME